Cordero-Coma et al. identified systemic comorbidities—including spondyloarthritis, juvenile idiopathic arthritis (JIA), and sarcoidosis—in 62.5% (5/8) of AAA-positive patients [24]. This evidence concerns the gene AAAS and sarcoidosis.